1st Quarter - Report

BLUE MOUNTAIN STRATEGIES for SIXTEENTHIRTY FUND

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act.

LobbyistCovered position, as disclosed
LUKE ALBEE —

Contacted: SENATE

Bills named: H.R. 448 (116th)

Health Issues HCR

Issues that encompass attempts to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 447 - Affordable and Safe Prescription Drug Importation Act. Issues involving the attempts to amend the Patient Protection and Affordable Care Act to ensure that preexisting condition exclusions with respect to enrollment in health insurance coverage and group health plans continue to be prohibited. HR 383 - Continuing Coverage for Preexisting Conditions Act of 2019.

LobbyistCovered position, as disclosed
LUKE ALBEE Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis.

Contacted: SENATE

Bills named: H.R. 447 (116th), H.R. 383 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.